Devices escape major cuts in US Medicare deal
This article was originally published in Clinica
The US Senate voted late yesterday afternoon (Tuesday December 18) to approve a $6bn Medicare package with no major cuts affecting medical devices. The bill has was significantly scaled back in recent weeks to win quick approval before Congress leaves town for the December break, causing some to breathe a sigh of relief.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.